Accel Wealth Management’s Zomedica Corp. ZOM Stock Holding History

Accel Wealth Management’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,830	Closed	-$1.66K	–	939
2023 Q1	$1.66K	Hold	7,830	–	–	﹤0.01%	1118
2022 Q4	$1.28K	Hold	7,830	–	–	﹤0.01%	943
2022 Q3	$2K	Hold	7,830	–	–	﹤0.01%	956
2022 Q2	$2K	Hold	7,830	–	–	﹤0.01%	922
2022 Q1	$3K	Hold	7,830	–	–	﹤0.01%	867
2021 Q4	$2K	Hold	7,830	–	–	﹤0.01%	897
2021 Q3	$4K	Hold	7,830	–	–	﹤0.01%	777
2021 Q2	$7K	Hold	7,830	–	–	﹤0.01%	756
2021 Q1	$12K	Buy	+7,830	New	+$12.8K	0.01%	631

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Accel Wealth Management's ZOM Position: Q2 2023 in Review

Accel Wealth Management sold out of Zomedica Corp. (ZOM) in Q2 2023, closing a stake of 7,830 shares — an estimated $1.66K sold.

Accel Wealth Management first reported a position in ZOM in Q1 2021 and held it in 9 quarters. The position peaked at $12K in Q1 2021. 92 funds tracked by Wall St. Rank hold ZOM as of Q2 2023.

Accel Wealth Management reported no remaining Zomedica Corp. position as of Q2 2023 after selling out during the quarter.
Accel Wealth Management sold 7,830 Zomedica Corp. shares in Q2 2023, an estimated $1.66K.
Accel Wealth Management first reported a position in Zomedica Corp. in Q1 2021 and held it in 9 quarters.
Accel Wealth Management's Zomedica Corp. position peaked at $12K in Q1 2021.
92 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2023.

Based on Accel Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.